SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QLT PhotoTherapeutics (QLTI)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ian@SI who wrote (868)4/10/2000 12:09:00 PM
From: Julian   of 1321
 
Biotech 2000: Invest in Your Future, After a Period of Lean Years, Biopharmaceuticals Bounce Back
9:37 EST Monday, April 10, 2000

MONTREAL, QUEBEC--At the onset of the new millennium, the Canadian biotechnology industry holds promising growth potential. This will be what eight Canadian public companies hosting the +Biotech 2000 - Invest in your future+ Investor Roadshow will tell you during a national tour brought to you by AnorMED Inc., Axcan Pharma Inc., Cangene Corporation, IBEX Technologies Inc., Inex Pharmaceuticals, Nortran Pharmaceuticals Inc., QLT PhotoTherapeutics Inc. and Stressgen Biotechnologies Corp.

After having been virtually ignored by the investment community in 1997 and 1998, the biopharmaceutical industry surprised a good number of investors these last few months by hitting record highs. The TSE Biotech index boasted a 50 % return between December 1998 and February 2000, compared with 38 % for the TSE 300.

Over the last few years, not only did some of the presenting companies launch new medications they successfully developed, but the whole biotechnology industry has shown considerable advances in its quest towards the approval of new medications. R & D efforts in the development of new technologies in areas as diversified as the use of metal in medicine, gastroenterology, the development of plasma-based products, use of enzymes in the treatment of cardio-vascular disease, oncology, respiratory diseases, photodynamic therapy and the development of immuno-therapeutic products, can considerably increase quality of life in the future.

These eight companies, active in the areas of research and development along with the production and commercialization of medications, will highlight their future prospects, and will show that now, more than ever, is the time to invest in the biotechnology sector. Investing in biotechnology is investing in your future.

You are invited to join us for a complimentary luncheon buffet followed by brief company presentations, at one of following locations:

Montreal Wednesday, April 12, 2000 at 11:30 Bonaventure Hilton Hotel
Toronto Thursday, April 13, 2000 at 11:30 King Edward Hotel

You can access a brief overview of these companies on the internet site www.smallcapcenter.com

The tour is organized directly by the hosting companies and is sponsored by Catalyst, ITG and KPMG.

Come join us - it's an event not to be missed. To register, please contact Michael Midmer at 1-800-330-9928
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext